Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. BERLIN — For years, scientists have held out hope that tests that look ...
A new treatment option for certain patients with blood cancers has passed muster with the European Commission (EC). Zemcelpro, made by ExCellThera subsidiary Cordex Biologics, is a one-time cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results